Protalix Biotherapeutics, Inc. (PLX)
1.745
0.00 (0.00%)
USD |
NYAM |
Dec 09, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics Market Cap: 140.34M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GlucoTrack, Inc. | 161.26M |
| PAVmed, Inc. | 9.812M |
| AIM ImmunoTech, Inc. | 1.123M |
| Perspective Therapeutics, Inc. | 186.96M |
| Armata Pharmaceuticals, Inc. | 217.62M |
Market Cap Related Metrics
| PE Ratio | 25.11 |
| PS Ratio | 2.219 |
| Price to Book Value | 2.652 |
| Price | 1.745 |
| Earnings Yield | 3.98% |
| Operating PE Ratio | 21.55 |
| Normalized PE Ratio | 25.11 |